INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 117 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $441,570 | -53.0% | 538,500 | -10.6% | 0.00% | -100.0% |
| Q4 2022 | $939,432 | +0.3% | 602,200 | +10.9% | 0.00% | 0.0% |
| Q3 2022 | $937,000 | +8.8% | 543,100 | +9.2% | 0.00% | 0.0% |
| Q2 2022 | $861,000 | -51.8% | 497,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,786,000 | -22.7% | 497,500 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $2,309,000 | -29.9% | 462,800 | +0.6% | 0.00% | -50.0% |
| Q3 2021 | $3,295,000 | -22.0% | 460,200 | +1.0% | 0.00% | -33.3% |
| Q2 2021 | $4,224,000 | -3.6% | 455,700 | -3.5% | 0.00% | 0.0% |
| Q1 2021 | $4,384,000 | +30.8% | 472,400 | +24.7% | 0.00% | +50.0% |
| Q4 2020 | $3,351,000 | -19.4% | 378,700 | +5.7% | 0.00% | -33.3% |
| Q3 2020 | $4,156,000 | -52.7% | 358,300 | +10.0% | 0.00% | -57.1% |
| Q2 2020 | $8,778,000 | +2352.0% | 325,700 | +86.3% | 0.01% | – |
| Q3 2019 | $358,000 | -26.2% | 174,800 | +5.9% | 0.00% | -100.0% |
| Q2 2019 | $485,000 | -21.1% | 165,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $615,000 | -1.8% | 165,000 | +5.5% | 0.00% | 0.0% |
| Q4 2018 | $626,000 | -28.0% | 156,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $870,000 | +41.9% | 156,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $613,000 | -16.8% | 156,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $737,000 | +28.6% | 156,400 | +12.8% | 0.00% | 0.0% |
| Q4 2017 | $573,000 | -34.8% | 138,700 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $879,000 | -1.3% | 138,700 | +22.0% | 0.00% | 0.0% |
| Q2 2017 | $891,000 | +18.3% | 113,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $753,000 | -4.6% | 113,700 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $789,000 | -25.6% | 113,700 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $1,060,000 | +0.9% | 113,700 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,051,000 | +12.4% | 113,700 | +2.2% | 0.00% | 0.0% |
| Q1 2016 | $935,000 | +54.0% | 111,200 | +23.0% | 0.00% | +100.0% |
| Q4 2015 | $607,000 | +16.1% | 90,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $523,000 | -16.1% | 90,400 | +18.3% | 0.00% | -50.0% |
| Q2 2015 | $623,000 | +12.9% | 76,400 | +13.0% | 0.00% | +100.0% |
| Q1 2015 | $552,000 | -11.1% | 67,600 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $621,000 | – | 67,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |